Results 41 to 50 of about 18,622 (204)
Neurocardiology: Brain–Heart Interactions in the Heart
The heart and brain maintain systemic homeostasis through bidirectional communication involving neural, biochemical, and mechanical pathways. Dysregulation of these pathways contributes to a spectrum of conditions involving heart–brain interactions, including Takotsubo syndrome, the epileptic heart, stroke–heart syndrome, heart failure, cardiac ...
Wentao Wang +3 more
wiley +1 more source
Salvage of ischemic myocardium by dipyridamole in the conscious dog.
We investigated the effect of i.v. dipyridamole, a potent small-vessel coronary vasodilator, on myocardial infarct size in conscious dogs. Dipyridamole, 7-9.7 microgram/kg; 15 dogs) or saline (15 dogs) was infused for 6 hours beginning 10 minutes after ...
B I Jugdutt +3 more
core +1 more source
Dipyridamole for tracking amyloidogenic proteins aggregation and enhancing polyubiquitination
Dipyridamole is currently used as a medication that inhibits blood clot formation and it is also investigated in the context of neurodegenerative and other amyloid related diseases.
Nadia Licciardello +20 more
core +1 more source
The Evaluation of In Vitro Effects of Dipyridamole on Coronary Artery Bypass Grafts
Objective: The aim of this study is to evaluate the efficacy of dipyridamole in relieving the vasospasm of coronary artery bypass grafts. Material and Methods: Twenty two patients who underwent elective coronary artery bypass grafting (CABG) were ...
Turan Ege +5 more
doaj
The clinical manifestations of PFO. Although the majority of PFOs are benign and asymptomatic, they can present with a variety of clinical manifestations, or coexisting with other diseases and aggravating their symptoms, including cerebral diseases (such as CS, epilepsy, TIA, or migraine), systemic embolism (such as embolism in renal artery, coronary ...
Linlin Meng +6 more
wiley +1 more source
Dipyridamole potentiates the cytotoxicity of N10-propargyl-5,8-dideazafolic acid (CB3717), an antifolate inhibitor of thymidylate synthase, by inhibiting both thymidine (TdR) salvage and deoxyuridine (UdR) efflux.
Harris AL, Curtin NJ, Newell DR
core +3 more sources
Effects of Dpyridamole on Histopathology of Salivary Glands in Rabbits [PDF]
Aims: Dipyridamole is a well-known coronary vasodilator. It is an adenosine reuptake inhibitor leading to increased blood levels of adenosine. So, this study aims to investigate the effects of systemic administration of dipyridamole on the salivary gland
Abdulsattar S. Mahmood +2 more
doaj +1 more source
ABSTRACT Aim To analyse the clinical, technical, and demographic factors associated with tunnelled central venous catheter dysfunction in patients undergoing haemodialysis. Design Multicentre, retrospective session‐level observational study. Methods We analysed 40,193 haemodialysis sessions from 743 patients with tunnelled central venous catheters ...
Verónica Gimeno Hernán +7 more
wiley +1 more source
Molecular Docking Reveals the Potential of Aliskiren, Dipyridamole, Mopidamol, Rosuvastatin, Rolitetracycline and Metamizole to Inhibit COVID-19 Virus Main Protease [PDF]
Drug repurposing is a fast way to rapidly discover a drug for clinical use. In such circumstances of the spreading of the highly contagious COVID-19, searching for already known drugs is a worldwide demand.
Omar, Aly, Omar Aly (8649477)
core +1 more source
Dipyridamole Can Augment the Resistance to Parathormone in Chronic Renal Failure
Dipyridamole which is used for vasodilatation might enhance renal tubular reabsorption of phosphate. In this study, we aimed to investigate the effect of dipyridamole on Ca, P metabolism, PTH, renal functions and electrolytes in pre-dialysis patients ...
Mustafa BALAL +4 more
doaj

